Novo Nordisk reported 34.08B in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Bausch Health Companies USD 605M 18M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
Merck USD 6.36B 149M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Novo Nordisk DKK 42.22B 8.39B Mar/2025
Pacira USD 10.23M 2.21M Jun/2025
Sanofi EUR 1.51B 1.39B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025